Skip to main content
An official website of the United States government

immunomodulatory agent CC-11006

A proprietary, orally available, small molecule and thalidomide analog, with potential immunomodulating and antineoplastic activity. CC-11006 appears to have a similar mechanism to thalidomide and may modulate the expression of proinflammatory and regulatory cytokines.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Code name:CC-11006
CC-11006-MDS-001
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search